Rx only · Prescription requiredA compounded GHK-Cu, BPC-157 and TB-500 protocol, considered only after a licensed provider reviews your intake. From $149/mo on a 12-month plan, example price.





Rx only · Prescription requiredCompounded GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg · 70 mg per vial · prescribed by a licensed provider
Starting at $199/mo — example price; lower monthly rate when you prepay a longer plan. Charged only after a provider approves your plan. Includes provider review, ongoing care-team messaging, medication and discreet shipping, if prescribed.
Start consultationAnswer a short health questionnaire about your goals, history and current medications. About 10 minutes.
A licensed US provider reviews your intake and may ask follow-up questions or schedule a video visit.
If treatment is right for you, your provider writes a prescription and a care plan. If not, you are not charged for medication.
A licensed US 503A pharmacy compounds your prescription and ships it discreetly to your door.
| Online consultation | Free |
| Licensed provider review | Included |
| Medication, if prescribed | Monthly supply |
| Care-team messaging | Unlimited |
| Refill check-ins | Before every refill |
| Discreet shipping | Included |
Copper peptide (glycyl-histidyl-lysine with copper)
Synthetic 15-amino-acid peptide
Synthetic fragment of thymosin beta-4
Final formulation is determined by your prescription and the dispensing pharmacy.
An independent clinician licensed in your state reviews your intake, decides whether Glow is appropriate, and sets your directions and follow-up.
Provider network: [partner TBD]
A licensed US 503A compounding pharmacy prepares your prescription to USP standards, labels it for you, and ships it with tracking.
Pharmacy partner: [503A partner TBD]
Prescription required. Eligibility determined by a licensed provider. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. This summary does not include all information about this treatment and does not replace a conversation with your provider. placeholder: final ISI to be written and approved by the medical director and pharmacy partner
To report side effects, contact your care team or the dispensing pharmacy. You may also report to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Glow is considered only after a licensed provider reviews your intake. It is not appropriate for everyone, including people who are pregnant or breastfeeding, have an active cancer or a history of certain cancers, or have a known allergy to any ingredient. Your provider decides.
A compounded combination of GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg (70 mg total per vial), prepared to your prescription by the pharmacy. Final formulation, strength and directions are set by your provider and pharmacy.
Your provider and pharmacy give you written directions, and your care team is available by message. Do not change how you use any medication without talking to your provider.
Results vary, and no outcome is guaranteed. Your provider will check in before each refill.
No. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness.
Rx only
Rx only
Rx only
Rx only